2019 Research With Cannabis Sativa and Lymphoma Cells

2019 Research With Cannabis Sativa and Tcells

“Synergistic Cytotoxic Activity of Cannabinoids from Cannabis sativa Extracts on T Cells Associated with Cutaneous T Cell Lymphoma Cell Lines

https://www.newswire.ca/news-releases/agmedica-bioscience-inc-confirms-collaboration-on-research-paper-presented-during-2019-institute-of-cannabis-research-conference-in-colorado-811425453.html

MedC’s and AgMedica’s recognition represents a significant milestone for the Company as it seeks to expand the identification and development of clinically-validated cannabis-derived medicines that can provide substantiated health and wellness benefits – particularly related to oncology.

This research is in process: For further information: For media or other inquiries, please contact: AgMedica Bioscience Inc., Sengkee Ahn, MBA, FEA, Vice President, Investor Relations and International Business Development, P: 1-844-247-4633, E: info@AgMedica.ca